Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT02580669
Eligibility Criteria:
Inclusion Criteria :
* For Both patients and healthy volunteers :
* Age limits ≥ 30 et ≤ 50 years
* Subject able to understand the nature, the aim and the methodology of the study.
* Collection of the informed consent
* Affiliation or recipient with the mode of social security.
* For the patients :
* Suffering from progressive multiple sclerosis (primary progressive forms or secondary progressive forms) OR
* Suffering from relapsing-remitting multiple sclerosis
Exclusion Criteria :
* For Both patients and healthy volunteers :
* Systemic pathology with neurological manifestations
* Antecedent of psychiatric disorders including psychosis (Except anxious depressive disorder)
* Subject presenting contraindications in MRI (Ferromagnetic foreign bodies, pace-maker)
* Claustrophobia
* Women pregnant or Breast-feeding
* Person with majority age protected by the law (supervision, trusteeship or under safeguard of justice).
* Subject unable to understand the nature and the aim of the study and/or communication difficulties with investigator
* Antecedent of serious cranial trauma (according to classification) of ischaemic stroke ou intracranial hematoma.
* For the patients :
* Antecedent of serious cranial trauma (according to classification), anterior or evolutive neurologic disease other than multiple sclerosis
* Recent relapse of multiple sclerosis
* For the healthy volunteers :
* Antecedent of serious cranial trauma (according to classification), anterior or evolutive neurologic disease
* Antecedent of neurological disease
* In period of exclusion relative to another protocol or which the annual amount of the allowances maximum of 4500 € was reached.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
50 Years
Study:
NCT02580669
Study Brief:
Protocol Section:
NCT02580669